Quest Diagnostics reported third-quarter earnings above market expectations. Despite raising full-year guidance, its share price fell 6.8% after the announcement.
Quest Diagnostics reported third-quarter results that exceeded analyst expectations. Although the article does not provide figures for the key items, results above market expectations were reported.
The company's share price fell 6.8% after the earnings announcement. Both the results and the market's reaction have been reported in connection with the share price movement.
The company reportedly raised its full-year guidance. The guidance increase may have been presented as a factor supporting the positive reception to the results.